The aim of the study is to offer new insights in PCOS patients strictly selected in order to avoid confounding factors such as dyslipemia, obesity, altered glucose/insulin metabolism, cardiovascular disease, or cancer. This evidence concerns the gene INS and polycystic ovary syndrome.